Overview
Ischemic heart disease (IHD) encompasses conditions where reduced blood flow to the heart muscle leads to myocardial ischemia, often due to atherosclerotic plaque formation in coronary arteries, causing significant morbidity and mortality globally.Diagnosis
Management
Special Populations
Key Recommendations
References
Showing 100 most recent of 6732 indexed papers.
1 Nichols S, Dawkes S, Cowie A, Brown S, Berry C, Humphreys H. Cardiovascular Prevention and Rehabilitation for Ischaemic Non-Obstructive Coronary Artery Disease: Implementation Considerations From a Survey of UK Health Professionals. Journal of advanced nursing 2026. link 2 Santos FS, Carvalho MS, Costa JSDD. Trend of avoidable mortality due to circulatory system diseases and ischemic heart diseases in Rio Grande do Sul (2000-2023): an ecological analysis. Revista da Associacao Medica Brasileira (1992) 2026. link 3 de Carvalho VS, da Silva LF, de Sousa CAM. Distinguishing stroke from mimics in telemedicine: How well does the TM-Score perform in a Brazilian telestroke network?. Journal of telemedicine and telecare 2026. link 4 de Oliveira DF, Maciel L, Dos Santos Silva A, Da Coutinho KC, Palhano FL, Santiago MF et al.. The C-domain of the cerebral dopamine neurotrophic factor (CDNF) is responsible for its cardioprotective activity by binding to the KDEL receptor relocated to the plasma membrane under endoplasmic reticulum stress conditions. Journal of molecular and cellular cardiology 2026. link 5 Härkänen T, Tapanainen H, Sares-Jäske L, Männistö S, Kaartinen NE, Paalanen L. Novel Pooling Method for Nonlinear Cohort Analysis and Meta-analysis Estimates: Predicting Health Outcomes from Dietary Changes. Epidemiology (Cambridge, Mass.) 2026. link 6 Voesenek BJB, Rutten JW, Mulder MPC, Mei H, Nibbeling EAR, van Etten ES et al.. A Novel APP p.V742L variant in a patient with ischemic small vessel disease enhances FE65 signalling. Neurobiology of disease 2026. link 7 Parker LE, Thomas MC, Williams AB, Weirnick R, Ogliari AS, Karpurapu A et al.. A Hypoxia-reoxygenation Injury Model in Self-assembling Human Cardioids. Journal of visualized experiments : JoVE 2026. link 8 Hoppe S, Prinz A, Kotz D, Mons U, Kuss O, Crutzen R et al.. Physical activity advice from general practitioners in Germany: findings from a cross-sectional population survey of individuals with chronic ischaemic heart disease (OptiCor study). BMJ open 2026. link 9 Bandy L, Amies-Cull B, Luick M, Cobiac LJ, Jebb SA, Scarborough P. Estimating the Potential Impact of the 2024 UK Salt Reduction Targets on Cardiovascular Health Outcomes and Health Care Costs in Adults: A Modeling Study. Hypertension (Dallas, Tex. : 1979) 2026. link 10 Mascia G, Cammarano M, Palmieri V, Monti R, Bona RD, Vergallo R et al.. Coronary CT angiography in master athletes: Redefining primary prevention of ischemic heart disease beyond the Italian 2023 COCIS guidelines. International journal of cardiology 2026. link 11 Ma Y, Guan L, Li X, Zhang J, Li X, Mu Y. Investigation Into the Utility of 3D Speckle-Tracking Echocardiography in Detecting Coronary Artery Microcirculation Dysfunction in Ischemia With Non-Obstructive Coronary Artery Disease. Journal of clinical ultrasound : JCU 2026. link 12 Madrid MK, Trampel KA, Salman B, George SA, Efimova T, Knollmann B et al.. Selective RyR2 inhibition reduces arrhythmia susceptibility in human cardiac slices. The Journal of physiology 2026. link 13 Gao H, Pan D, Santos HA. Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease. Advanced materials (Deerfield Beach, Fla.) 2026. link 14 Guida G, Castelvecchio S, Disabato G, Attanasio A, Camporeale A, Tondi L et al.. Long-term outcomes of surgical ventricular reconstruction: Insight from cardiac magnetic resonance. International journal of cardiology 2026. link 15 Gül S, Taşdemir R, Açıkgöz B, Duman H, Hodzic H, Köker S et al.. A Multimodular AI Algorithm for Automated Assessment of Left Ventricular Function in Ischemic Heart Disease: Ejection Fraction, Wall Motion, and Regional Myocardial Segmentation. Balkan medical journal 2026. link 16 Xing Z, Abudureyimu S, Abulaiti P, Wang Y, Lyu M, Gao Y. Role of IFI204 in Modulating NF-ΚB Pathway and Myocardial Protection in Ischemia-Reperfusion Injury. Shock (Augusta, Ga.) 2026. link 17 Izumi A, Yau TM, Fedak PWM, Fatehi Hassanabad A. Pericardial Delivery of Stem Cells: An Emerging Frontier in Myocardial Regeneration for Ischemic Heart Disease. The Canadian journal of cardiology 2026. link 18 Muir KC, Stone C, Reddy R, Kanuparthy M, Hamze J, Harris DD et al.. Sotagliflozin Enhances Left Ventricular Function and Myocardial Perfusion in Chronic Myocardial Ischemia Through Metabolic and Redox Remodeling. Arteriosclerosis, thrombosis, and vascular biology 2026. link 19 Zhang AJ, Chelu MG, Taing K, Birnbaum Y. P-wave peak time: An emerging electrocardiographic marker of atrial stress and ischemic burden-review. Journal of electrocardiology 2026. link 20 Gong T, Wang D, Jin Y, Chen L, Qiu N, Qiu W et al.. Sphk2 suppresses ferroptosis in ischemic hearts by promoting HSP90AA1-mediated TFEB nuclear translocation, lysosome biogenesis and lysosome-autophagy pathway-dependent lipid-ROS clearance. Metabolism: clinical and experimental 2026. link 21 Aggarwal K, Singh S, Singla A, Kanagala SG, Anamika F, Singh B et al.. Unveiling the Silent Intruder: H. pylori's Hidden Link to Ischemic Heart Disease. Cardiology in review 2026. link 22 Enkhtaivan B, Yusupova AO, Slepova OA, Pakhtusov NN, Belenkov YN, Siplivyy VI et al.. Microcirculatory Features of the Conjunctiva and Retina in Patients with Stable Ischemic Heart Disease and Various Patterns of Coronary Artery Involvement. Kardiologiia 2026. link 23 Xue L, Zhang Q, Wang Y, Zhan W, Cui M, Peng N et al.. S100A11/ANXA2 axis mediates electrotransduction to promote electrically-induced contraction in engineered myocardial tissues. Biomaterials 2026. link 24 Chae M, Yoon S, Lee HJ, Jang WS, Kim YS, Cho J et al.. Outcomes of ischemic mitral regurgitation after coronary revascularization alone in patients with acute coronary syndrome. The Journal of thoracic and cardiovascular surgery 2026. link 25 Teimoori A, Orhan H, Zeynalova N, Demirtaş E, Efe O, Özer H et al.. Effect of slow-release hydrogen sulfide donor GYY4137 on vascular smooth muscle and endothelial response in an in vitro ischemia-reperfusion model of rat thoracic aorta. Canadian journal of physiology and pharmacology 2026. link 26 Tamarappoo B, Wolny R, Tomasino GF, Berman D, Handberg E, Pepine CJ et al.. Design and rationale of the WARRIOR ancillary study for coronary CT angiographic analysis. American heart journal 2026. link 27 Lu D, Chen D, Cao R, Zhang X, Liang J, Zhu F et al.. Overexpression of OTUD5 in IPSCs-derived extracellular vesicles promotes angiogenesis after myocardial infarction by inhibiting endothelial cell ferroptosis. Nutrition, metabolism, and cardiovascular diseases : NMCD 2026. link 28 Schindler TH, Arai AE, Berry C, Sykes R, Nieman K, Kitagawa K et al.. Myocardial Blood Flow Assessment and Reporting for Ischemic Heart Disease: Cardiac PET, MR, CT, and Echocardiography. JACC. Cardiovascular imaging 2026. link 29 Sakboonyarat B, Lakshminarayan K, Rangsin R. National Trends and Factors Associated with Ischemic Heart Disease Among Individuals with Hypertension in Thailand from 2011 to 2018. Global heart 2026. link 30 Basit J, Hanmandlu A, Husainy B, Awad A, Alraies MC. Patient Selection, Referral Framework and Emerging Therapies in Severe Ischemic Heart Failure: A State-of-the-Art Review. Heart failure clinics 2026. link 31 Vartanian-Grimaldi JS, Agbulut O. A human cardiomyocyte-based cellular model mimicking cardiac ischemia. American journal of physiology. Cell physiology 2026. link 32 Hafez A, Sobhy A, Ashour M, Aiash K, Aldemerdash A, Radi AM et al.. Diagnostic Performance of AI-Assisted Coronary CT Angiography: A Systematic Review and Meta-Analysis. European journal of radiology 2026. link 33 Ishikane S, Kishigami T, Ikushima E, Arioka M, Igawa K, Takahashi-Yanaga F. Postoperative administration of 2,5-dimethylcelecoxib attenuates ischemia-reperfusion injury-induced cardiac dysfunction. Journal of pharmacological sciences 2026. link 34 Kutlu Z, Halici Z, Tavaci T, Karcioğlu SS, Yildirim S, Bayraktutan Z et al.. Breaking the vicious cycle: Avasopasem manganese disrupts ER Stress-Oxidative damage crosstalk in ischemic cardiac injury in type 1 diabetic mice. European journal of pharmacology 2026. link 35 Liao W, Zhang L, Liu S, Zhou R, Wu D, Yan H et al.. IL6 Regulates Glutamate/Haptoglobin-Induced Ferroptosis via the JAK2/STAT3 Axis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026. link 36 Jumani M, Tabassum S, Kumar V, Haris M, Hammad A, Kumari K. Ischemia with nonobstructive coronary arteries: Insights into diagnostic approaches. Asian cardiovascular & thoracic annals 2026. link 37 DeVon HA, Tintle N, Rivera E, Davis A, Dunn SL. Assessment of Discriminant Validity for Measures of Hope and Hopelessness in Adults With an Acute Cardiac Event. Research in nursing & health 2026. link 38 Sakai A, Nagao M, Yamamoto A, Nakao R, Kawakubo M, Arashi H et al.. Prognostic value of . International journal of cardiology 2026. link 39 Florit Gonzalez L, Bouwman M, Bakkers J. Past, Present and Future of Regenerative Gene Therapy for Ischemic Heart Failure. Journal of cardiovascular translational research 2026. link 40 Radaelli D, Alshaeb A, Al-Habash I, Belakaposka Srpanova V, Jakovski Z, Sinagra G et al.. Reading the Signature of Autophagy in the Ischemic and Infarcted Heart: A Systematic Review of Circulating Biomarkers. International journal of molecular sciences 2026. link 41 Hamik M, Schindler S, Moshammer H. Analysis of potential health impacts of road and rail traffic noise, using noise at residential locations in Austria as an example. Wiener klinische Wochenschrift 2026. link 42 Ahmad M, Ibrahim M, Ijaz M, Hanif MF, Kumar A, Chaudhry W et al.. Uncovering the burden of depression on ischemic heart disease mortality in the United States: A 25-year population study. Journal of affective disorders 2026. link 43 Liang Y, Zhang X, Duan M, Hu C, Li H, Yang M. Global burden of ischemic heart disease attributable to dietary risks in young adults, 1990-2021: trends and future projections. Frontiers in public health 2026. link 44 Sønnichsen-Dreehsen AS, Thorarinsson CT, Nørgård BM, Fedder J, Wod M. Paternal ischemic heart disease and chance of successful pregnancy outcomes. Andrology 2026. link 45 Wang Y, Feng B, Wu Y, Sun Z, Yuan H, Chen W et al.. Mitochondria-associated endoplasmic reticulum membranes: Emerging regulators of cardiac microvascular ischemia/reperfusion injury (Review). International journal of molecular medicine 2026. link 46 Rodríguez de Rivera M, Zubiaur J, Cucurull Ortega I, Carreiro Da Cunha E, Pérez Barquín R, Margarida de Castro A et al.. Sex and gender disparities in ischemic heart disease: The role of social and clinical factors in long-term outcomes from the RECORVAL registry. Medicina clinica 2026. link 47 Maiouak M, Cherti M, Youbi M, Belakhel L, Abouselham L, El Fakir S et al.. Economic Burden of Ischemic Heart Disease in Morocco: Evidence From a Teaching Hospital, a Cost-of-Illness Study. Value in health regional issues 2026. link 48 Matsuzawa Y, Ishii M, Kusaka H, Yamashita T, Yamamoto E, Tsujita K. Interventional diagnostic procedures in INOCA: an essential approach in ischemic heart disease. Cardiovascular intervention and therapeutics 2026. link 49 Alotaibi M, Cajita M, Tintle NL, DeVon HA, Marquez DX, Luong A et al.. Associations Among Perceived Social Support, Physical Activity, and Health-Related Quality of Life in Patients With Ischemic Heart Disease Reporting Moderate to Severe Hopelessness. The Journal of cardiovascular nursing 2026. link 50 Dhalla NS, Elimban V, Ostadal P. Improvement of Cardiac Function by Polyclonal Antibodies Against Ca. International journal of molecular sciences 2026. link 51 Xiao H, Zhang W, Liu J, Ma Y, Liu D, Li M et al.. Engineered Therapeutic Nanoplatforms for Ischemic Heart Disease Treatment Vis Cardiac Microenvironment Reprogramming. Advanced healthcare materials 2026. link 52 Hummel B, van Schalkwijk DL, Zipfel N, Tuithof PTC, Mommersteeg PMC, Harskamp RE et al.. Implementation and product- and process evaluation of a co-created gender-informed and culturally-sensitive toolkit to improve symptom recognition and care seeking for ischemic heart disease: RE-AIM framework. PloS one 2026. link 53 Dungan JR, Taha YK, Pei Q, Weaver MT, Tavormina MJ, Reis SE et al.. Electrocardiographic Predictors of Major Adverse Cardiovascular Events in Women With Suspected Ischemia and no Obstructive Coronary Artery Disease: Results of the Women's Ischemia Syndrome Evaluation. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2026. link 54 Lee Y, Wu X, Narayanan A, Chakraborty S, Heaps CL, Muthuchamy M. Exercise training ameliorates myocardial dysfunction through fibronectin-mediated mechanotransduction in a swine model of ischemic heart disease. American journal of physiology. Heart and circulatory physiology 2026. link 55 Ikeda A, Fukushima K, Ishii S, Endo K, Katahira M, Ukon N et al.. Assessment of left ventricular mechanical synchrony and intraventricular blood flow energy in ischemic heart disease using a hybrid positron emission tomography-magnetic resonance system. International journal of cardiology 2026. link 56 Obrutu O, Gulati M, Reis S, Bittner V, Handberg E, Cook-Wiens G et al.. Persistent chest pain trends at 3 years in women with INOCA vs. obstructive CAD: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE). European heart journal. Quality of care & clinical outcomes 2026. link 57 He K, Wang H. Unearthing the global, regional, and national epidemiological landscapes of high BMI-driven ischemic heart disease burden in youth: Trends, determinants, and future trajectories. PloS one 2026. link 58 Leung ECH, Blankenship JC, Orellana CP, Hill D, Yarlagadda B. Disparities in access, utilization, and outcomes of percutaneous coronary intervention in Hispanics compared to non-Hispanic Whites in the United States: A comprehensive review. Cardiovascular revascularization medicine : including molecular interventions 2025. link 59 Cohn SL. 2024 ACC/AHA guideline on perioperative cardiovascular management before noncardiac surgery: What's new?. Cleveland Clinic journal of medicine 2025. link 60 Marchetti D, Conte E, Porto I, Zeppilli P, Andreini D. Ischemic heart disease. The Journal of sports medicine and physical fitness 2025. link 61 Wang SQ, Chen TY, Wang L, Cheng HX, Li HB, He CQ et al.. Cardiac rehabilitation in porcine models: Advances in therapeutic strategies for ischemic heart disease. Zoological research 2025. link 62 Dedic E, Vistisen HS, Zwisler AD, Pedersen BF, Kappel KL, Kanstrup H et al.. Patients' acceptability of a patient-reported outcome measure in cardiac rehabilitation (the PRO-Heart-DK)-a mixed methods study using the Theoretical Framework of Acceptability. Journal of patient-reported outcomes 2025. link 63 Javadi N, Dianati M, Taghadosi M. Why do patients with ischemic heart disease modify their lifestyle? a qualitative study : Motivations for lifestyle modification after IHD. BMC research notes 2025. link 64 Pedersen M, Overgaard D, Boateng T, Bennich B, Beck AM, Andersen I et al.. The Effect of Peer-Mentor Support for Older Vulnerable Patients With Ischemic Heart Disease-A 24-Week Randomized Controlled Trial. The Journal of cardiovascular nursing 2025. link 65 Kovell LC, Bothwick V, McCabe P, Juraschek SP, Meng Y, Revoori R et al.. Patterns of Adherence to Home Blood Pressure Monitoring Among Older Adults With Ischemic Heart Disease: An Analysis From the RESILIENT Trial of Mobile Health Cardiac Rehabilitation. Journal of cardiopulmonary rehabilitation and prevention 2025. link 66 Delgado-Calderón M, Jiménez-Ortega LE, Ladisa M, Camacho-Vega JC, Vilches-Arenas Á, Luque-Romero LG et al.. Cardiac rehabilitation for workers with ischemic heart disease: Benefits for cardiovascular health and quality of life. Medicine 2025. link 67 Dodson JA, Adhikari S, Schoenthaler A, Hochman JS, Sweeney G, George B et al.. Rehabilitation at Home Using Mobile Health for Older Adults Hospitalized for Ischemic Heart Disease: The RESILIENT Randomized Clinical Trial. JAMA network open 2025. link 68 Hausvater A, Reynolds HR. Cardiac Rehabilitation for Patients With Ischemia and No Obstructive Coronary Arteries (INOCA) and Myocardial Infarction With No Obstructive Coronary Arteries (MINOCA): A Review. Journal of cardiopulmonary rehabilitation and prevention 2025. link 69 Pedersen M, Petersen RA, Boateng T, Egerod I, Overgaard D, Bennich BB. Peer-Mentor Support for Older, Vulnerable Patients With Ischemic Heart Disease: A Mixed Methods Process-Outcome Evaluation. Journal of advanced nursing 2025. link 70 Rawstorn JC, Subedi N, Koorts H, Evans L, Cartledge S, Wallen MP et al.. Stakeholder perceptions of factors contributing to effective implementation of exercise cardiac telerehabilitation in clinical practice. European journal of cardiovascular nursing 2025. link 71 Rasmussen B, Maribo T, Toft BS. Existential Well-Being and Suffering in the Context of Cardiac Rehabilitation: A Qualitative Interview Study. Scandinavian journal of caring sciences 2025. link 72 Maithreepala SD, Chao HY, Chen HM, Pimsen A, Shu BC. The Effect of Internet-Based Cardiac Rehabilitation on Anxiety, Depression, and Quality of Life Among Patients With Ischemic Heart Disease: A Systematic Review and Meta-analysis of Randomized Control Trials. The Journal of cardiovascular nursing 2025. link 73 Barua S, Upadhyay D, Pena S, McConnell R, Varghese A, Adhikari S et al.. Adherence to Accelerometer Use in Older Adults Undergoing mHealth Cardiac Rehabilitation: Secondary Analysis of a Randomized Clinical Trial. Journal of medical Internet research 2025. link 74 Lim P, Eris T, Shaw LJ, Gelfman LP, Gelijns AC, Moskowitz AJ et al.. Representation of Older Adults and Women in Randomized Trials of Noninvasive Imaging for Chest Pain. Circulation. Cardiovascular imaging 2025. link 75 Bustin A, Stuber M, de Villedon de Naide V, Villegas-Martinez M, Narceau K, Génisson T et al.. AI-powered SPOT imaging for enhanced myocardial scar detection and quantification. Nature communications 2025. link 76 Ates MS, Alptekin GS, Demirozu ZT, Zorman Y, Akcevin A. Off-Pump Revascularization in Moderate Ischemic Mitral Regurgitation. The Thoracic and cardiovascular surgeon 2025. link 77 Zhou Y, Rautio E, Näsman P, Gudbjörnsdottir S, Gadler F, Rydén L et al.. Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide registry-based cohort study. Cardiovascular diabetology 2025. link 78 Cai T, Yang XQ. Modified mRNA-Based Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury. International journal of molecular sciences 2025. link 79 Zhang J, Shen P, Wang Y, Li Z, Xu L, Qiu J et al.. Interaction between walkability and fine particulate matter on ischemic heart disease: A prospective cohort study in China. Ecotoxicology and environmental safety 2025. link 80 Ballavenuto JMA, Tongtip N, Fischer NLS, Bardus M. Wearable devices, ischemic heart disease and cardiovascular outcomes: A systematic review and meta-analysis. Maturitas 2025. link 81 Zhang X, Huang DX, Xuan C, Li Y, Jiang Y, Wu X et al.. Aerobic exercise training attenuates ischemia-reperfusion injury in mice by decreasing the methylation level of METTL3-associated m6A RNA in cardiomyocytes. Life sciences 2025. link 82 Zhang H, Li G, Wang X, Zhang Y. Global, regional, and national burden of kidney dysfunction-attributed ischemic heart disease from 1990 to 2021: A systematic analysis of the Global Burden of Disease study 2021. PloS one 2025. link 83 Yamada M, Nakadate Y, Omiya K, Oguchi T, Abe M, Matsukawa T. Cardioprotective effects of S-equol, a soybean metabolite with estrogen activity, and role of the PI3K/Akt pathway in a male rat model of ischemic reperfusion. Steroids 2025. link 84 Raja MS, Duric B, Khashkhusha A, Abbasi H, Goyal K, Harky A. Long Saphenous Vein Harvesting: Reviewing Various Techniques. Cardiology in review 2025. link 85 Al-Awar A, Khan AW, Hussain S. Myocardial stunning: mechanisms, molecular insights, and gaps in knowledge. Bioscience reports 2025. link 86 Hanada K, Sasaki S, Kinjo T, Shikanai S, Yamazaki K, Kato T et al.. Incidence and Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy in Japanese Ischemic Heart Disease Patients. Circulation journal : official journal of the Japanese Circulation Society 2025. link 87 Ryan M, Truesdell AG, Murphy GJ, Ezad SM, Fremes S, Lansky AJ et al.. Revascularization in Ischemic Left Ventricular Dysfunction: A Pathophysiology-Guided, Evidence-Based Approach. JACC. Cardiovascular interventions 2025. link 88 Wang X, He Y, Du Y, Li C, Zhang D. The dual role of ATF3 in myocardial repair through macrophage regulation. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2025. link 89 Dimitriadis K, Pyrpyris N, Sakalidis A, Dri E, Iliakis P, Tsioufis P et al.. ANOCA updated: From pathophysiology to modern clinical practice. Cardiovascular revascularization medicine : including molecular interventions 2025. link 90 Müller J, Koch L, Halbfass P, Nentwich K, Berkovitz A, Barth S et al.. A screening for cerebral deoxygenation during VT ablations in patients with structural heart disease. Clinical research in cardiology : official journal of the German Cardiac Society 2025. link 91 Wu J, Zhai J, Zhu X, Hao Q, Yang J, Li X et al.. Epidemiological characteristics of ischemic heart disease: A comparative study between China and the world from 1990 to 2021 and prediction to 2036. PloS one 2025. link 92 Vall-Roqué H, Ramos-García V, Rivero-Santana A, Torres-Castaño A, Cifuentes P, Koatz D et al.. A virtual community of practice to empower patients with recent ischemic heart disease: A randomized controlled trial. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2025. link 93 Mitchell G, Javan H, Nickel I, Valdez S, Palatinus JA, Szulik M et al.. Intravenous acellular human amniotic fluid prevents ischemic cardiac remodeling. Scientific reports 2025. link 94 Ong P, McChord J, Pereyra VM, Sechtem U, Bekeredjian R, Seitz A. New avenues for the assessment of stable ischemic heart disease. Clinical research in cardiology : official journal of the German Cardiac Society 2025. link 95 Wang L, Zhang J, Xiao X, Tang X, Tang J, Xu H et al.. Accelerometer-Derived Rest-Activity Rhythm Amplitude, Genetic Predisposition, and the Risk of Ischemic Heart Disease: Observational and Mendelian Randomization Study. Journal of medical Internet research 2025. link 96 Arichi M, Mugler DH, Fannin S. Direct mathematical method for real-time ischemic episodes detection from electrocardiograms using the discrete Hermite transform. Journal of electrocardiology 2025. link 97 Romiti GF, Buoninfante G, Basili S. Inflammation, lipids and cardiovascular risk: The quest for improving risk stratification and prognosis in ischemic heart disease. European journal of clinical investigation 2025. link 98 Hao SR, Xie ZF, Li JX, Wang QZ, Wu TT, Shen T et al.. Butorphanol Alleviates Hypoxia/Reoxygenation-Induced Myocardial Injury by Activating Wnt/β-Catenin Signal Pathway. Journal of applied toxicology : JAT 2025. link 99 Bellae Papannarao J, Coffey S, Gray A, Williams M, Katare R. Serial measurement of circulating cardiovascular-enriched microRNAs in patients with ischaemic heart disease - a five-year longitudinal study. Bioscience reports 2025. link 100 Liu D, Hu K, Wagner C, Lengenfelder BD, Ertl G, Frantz S et al.. Clinical value of a comprehensive clinical- and echocardiography-based risk score on predicting cardiovascular outcomes in ischemic heart failure patients with reduced ejection fraction. Clinical research in cardiology : official journal of the German Cardiac Society 2025. link